Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty
Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
Myocardial necrosis is relatively frequent after percutaneous coronary intervention and is
associated with higher mortality during the follow-up.
Since anti-inflammatory properties of statins have been demonstrated and the benefit of
statins in acute coronary syndromes have been proven, this study aims at testing the
hypothesis that the pre-procedural intensive statin treatment reduce the extent of
peri-procedural necrosis.
Phase:
Phase 3
Details
Lead Sponsor:
G. d'Annunzio University
Collaborator:
Working Group Aterosclerosi, Trombosi e Biologia Vascolare